Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 588 | 233 | 0 | 1,717 | 2,505 |
| Cost of Goods | N/A | N/A | N/A | 1,303 | 1,579 |
| Gross Profit | 588 | 233 | N/A | 414 | 926 |
| Operating Expenses | 10,342 | 9,994 | 0 | 4,925 | 3,611 |
| Operating Income | -9,754 | -9,761 | N/A | -4,208 | -2,106 |
| Interest Expense | 26 | 18 | 0 | 0 | 0 |
| Other Income | 294 | 374 | 0 | 140 | 28 |
| Pre-tax Income | -9,486 | -9,405 | 0 | -4,068 | -2,078 |
| Income Tax | N/A | -10,500 | N/A | N/A | N/A |
| Net Income Continuous | -9,486 | 1,095 | N/A | -4,068 | -2,078 |
| Net Income Discontinuous | -1,620 | -1,466 | N/A | N/A | N/A |
| Net Income | $-11,106 | $-371 | $N/A | $-4,068 | $-2,078 |
| EPS Basic Total Ops | -0.40 | 0.00 | N/A | -0.30 | -0.10 |
| EPS Basic Continuous Ops | -0.34 | 0.10 | N/A | -0.29 | -0.15 |
| EPS Basic Discontinuous Ops | -0.06 | -0.10 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.40 | 0.00 | N/A | -0.30 | -0.10 |
| EPS Diluted Continuous Ops | -0.34 | 0.10 | N/A | -0.29 | -0.15 |
| EPS Diluted Discontinuous Ops | -0.06 | -0.10 | N/A | N/A | N/A |
| EBITDA(a) | $-9,501 | $-9,572 | $N/A | $-4,151 | $-2,013 |